Correlation Between Shyam Metalics and Beta Drugs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Shyam Metalics and Beta Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shyam Metalics and Beta Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Shyam Metalics and and Beta Drugs, you can compare the effects of market volatilities on Shyam Metalics and Beta Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shyam Metalics with a short position of Beta Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shyam Metalics and Beta Drugs.

Diversification Opportunities for Shyam Metalics and Beta Drugs

0.03
  Correlation Coefficient

Significant diversification

The 3 months correlation between Shyam and Beta is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Shyam Metalics and and Beta Drugs in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Beta Drugs and Shyam Metalics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shyam Metalics and are associated (or correlated) with Beta Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Beta Drugs has no effect on the direction of Shyam Metalics i.e., Shyam Metalics and Beta Drugs go up and down completely randomly.

Pair Corralation between Shyam Metalics and Beta Drugs

Assuming the 90 days trading horizon Shyam Metalics is expected to generate 1.04 times less return on investment than Beta Drugs. But when comparing it to its historical volatility, Shyam Metalics and is 1.27 times less risky than Beta Drugs. It trades about 0.1 of its potential returns per unit of risk. Beta Drugs is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  72,950  in Beta Drugs on August 24, 2024 and sell it today you would earn a total of  125,350  from holding Beta Drugs or generate 171.83% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy99.8%
ValuesDaily Returns

Shyam Metalics and  vs.  Beta Drugs

 Performance 
       Timeline  
Shyam Metalics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Shyam Metalics and has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Shyam Metalics is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.
Beta Drugs 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Beta Drugs are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Beta Drugs unveiled solid returns over the last few months and may actually be approaching a breakup point.

Shyam Metalics and Beta Drugs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Shyam Metalics and Beta Drugs

The main advantage of trading using opposite Shyam Metalics and Beta Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shyam Metalics position performs unexpectedly, Beta Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Beta Drugs will offset losses from the drop in Beta Drugs' long position.
The idea behind Shyam Metalics and and Beta Drugs pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Stocks Directory
Find actively traded stocks across global markets
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments